pharma · Uveal Melanoma · HLA-A2 negative metastatic uveal melanoma · IDYA
IDEAYA Biosciences
IDEAYA Biosciences patent portfolio — 12 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 5000 Shoreline Ct, Suite 300, South San Francisco, California 94080, US
- Founded
- 2015
- Employees
- 248
- Programs
- 14
- Drugs
- 12
- Patents
- 12
IDEAYA Biosciences patents
12 pharmaceutical patents indexed for IDEAYA Biosciences. 0 expire within 24 months.
IDEAYA Biosciences has 12 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12398131
Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof
granted -
US 12269820
Piperazine substituted indazole compounds as inhibitors of PARG
granted -
US 12258354
AhR modulators
granted -
US 12115163
Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor
granted -
US 11584755
Dihydrothieno[3,2-b]pyridine compounds
granted -
US 11548867
Amido compounds as AhR modulators
granted -
US 11530220
Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhR
granted -
US 11407764
AhR modulators
granted -
US 11130759
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 11084798
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 11046691
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 10815250
AhR modulators
granted
Frequently asked questions
How many patents does IDEAYA Biosciences have?
12 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do IDEAYA Biosciences patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.